Key Record Dates
| ClinicalTrials.gov Identifier: | NCT01781572 |
|---|---|
| Brief Title: | A Phase Ib/II Study of LEE011 in Combination With MEK162 in Patients With NRAS Mutant Melanoma |
| First Submitted : | January 24, 2013 |
| First Submitted that Met QC Criteria : | January 30, 2013 |
| First Posted : | February 1, 2013 (Estimate) |
| Results First Submitted : | May 6, 2020 |
| Results First Submitted that Met QC Criteria : | July 24, 2020 |
| Results First Posted : | August 12, 2020 |
| Certification/Extension First Submitted : | December 14, 2018 |
| Certification/Extension First Submitted that Met QC Criteria : | December 14, 2018 |
| Certification/Extension First Posted : | December 19, 2018 |
| Last Update Submitted that Met QC Criteria : | November 23, 2020 |
| Last Update Posted : | December 7, 2020 |